Mission
The mission of the China International Center for Chronic Disease Prevention is to develop, implement and evaluate strategies for the treatment and prevention of the chief causes of ill health in China. We do this through a program of targeted health care initiatives, capacity building and policy engagement. The results help to expand the evidence-base upon which the Center can drive the implementation of better health policy for the control of chronic diseases effecting hundreds of millions of the of the most disadvantaged people in China.
Main strategy
To achieve our mission, our main strategy will:
- Implement targeted translational health care projects that will have measurable impact on important health outcomes in local communities.
- Develop local leadership and capacity to ensure that change is ongoing and sustainable.
- Raise awareness about the importance of addressing chronic disease through advocacy and engagement with policy makers from the grassroots through to senior national levels.
Innovation, impact and sustainability will underpin each component of the program with the primary strategy focusing on expanding capacity in health care services through leadership development, capacity building and re-training. Developing programs that keep costs low will ensure that our work can be widely implemented in even the very poorest sectors of Chinese society.
Cross-cutting objectives
The Center has four cross-cutting thematic objectives:
- Community Capacity Building: Our work we build local capacity to formulate and implement programs, engage stakeholders and advocate for better chronic disease outcomes for local communities.
- Leadership Transfer and Stakeholder Engagement: We will develop a new cadre of leaders and equip them with the skills required to engage and influence the key stakeholders that are responsible for health policy and healthcare delivery in China. Central to this goal will be our efforts to give greater profile to our Chinese partners that participate in our programs while providing them with the benefit of our experience at the international Centre.
- Generating Maximum Leverage: We will target funding from commercial, governmental and non-governmental supporters of chronic disease prevention to help boost investment in our programs. We will also work to persuade major donors, not already active in our field of research, to support chronic disease initiatives in developing regions.
- Communications and Dissemination: We will communicate and disseminate our work and our results to the widest audience through local, national and international media. In doing so, we will place high importance on communicating with local audiences in their local languages. We will also develop ways of reaching key national policy groups to drive real change in systems of care in China.
Sponsors
Our Center is one of 11 centers worldwide http://www.nhlbi.nih.gov/. The Center in China receives funding from the National Heart, Lung and Blood Institute and the UnitedHealth Group through the Global Health Initiative http://www.nhlbi.nih.gov/about/globalhealth/index.htm.
Partners
We are working with Peking University Health Sciences Center, to bring together ten leading national and international institutions that are active in chronic disease research, prevention and treatment. Broadly, these ten institutions comprise five leading academic institutions from the United States, Australia and the United Kingdom and five regional institutions that are serving large populations in rural China. These institutions all have significant national or international reputations and provide the broad range of skills and stakeholder relationships (from the highest national level to the grassroots community level) required to achieve our goals.
Our strategic partner is:
Peking University Health Sciences Center
The five international partner institutions are:
- Duke University, USA;
- The George Institute (Sydney, Australia and Beijing, China);
- The University of Sydney, Australia;
- The University of Queensland, Australia; and
- Imperial College London, England.
The five Chinese partner institutions are:
- The China Medical University, Liaoning;
- Xi’an Jiaotong University School of Public Health, Shaanxi;
- Hebei Provincial Centre for Disease Control and Prevention, Hebei;
- Ningxia Medical University School of Public Health, Ningxia; and
- Changzhi Medical College, Shanxi.
